Biotech Investments S.R.O
Venture studioPrague · Pre-Seed–Seed · 9 people tracked
Find your way into Biotech Investments S.R.O
945 people in our graph share verified history with the Biotech Investments S.R.O team — schools, employers, funds. One of them is your warm intro.
Investment thesis
i&i Prague operates as a biotech incubator and venture builder focused on commercialising early-stage life sciences innovation, including drug development, diagnostics, and medical technologies. It provides step-by-step support to scientists setting up companies, offering expert consulting across scientific, legal, and business areas. The organization emphasizes building a network of startups, investors, industrial partners, and biotechnology experts to enable collaboration and knowledge sharing. Its incubation program helps founders access market analysis, early industry feedback, initial funding, and connections to first investors.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website
What they invest in
from 17 of 18 portfolio companiesBiotech ×16Medical Devices ×9Healthtech ×8Deep Tech ×6New Materials ×6AI & Machine Learning ×3Cleantech ×1Consumer ×1
HQs:Czechia×9Germany×2European Union×1France×1United States×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×43 founders×34+ founders×1
Investments · 18 tracked
founders shown can be your intro path
Adalid Sciences engineers lipid nanoparticles to improve the delivery and efficacy of gene therapies, targeting better therapeutic outcomes with reduced side effects.
BiotechDeep TechMedical DevicesPrague, CZ
Petr Cigler(Co-Founder and Chief Scientific Officer)Frantisek Sedlak(Co-Founder and Chief Medical Officer)David Schreib(Co-Founder and Chief Commercial Officer)inKlara Grantz Saskova(Co-Founder and Chief Executive Officer)in
CasInvent Pharma develops pharmaceutical solutions, currently raising Series A funding through a crowdfunding campaign.
BiotechHealthtech
Alexander Scheer(CEO)in
Co-investorsJIC Venturesi&i Biotech Fund
Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises.
AI & Machine LearningBiotechDeep Tech
Jan Macek(Chief Executive Officer)inMiroslav Lžičař(Chief Technical Officer)inJiří Růžička(Chief Business Officer)in
DIANA Biotechnologies is a Czech biotech company that sells products and services to the life sciences research market through a distributed network of regional distributors and scientific marketplaces.
BiotechHealthtechMedical DevicesVestec, CZ
Martin Dienstbier(Co-CEO)
Co-investorsB3 Holding
Dracen Pharmaceuticals is a private drug developer working at the intersection of cancer metabolism and immuno-oncology, developing glutamine antagonists that inhibit tumor glutamine metabolism and remodel the tumor microenvironment.
BiotechHealthtechBaltimore, US
Robert Wild(Co-founder & Chief Scientific Officer)Thomas M. Estok(Chief Executive Officer, President and Treasurer)Drew Pardoll, M.D., Ph.D.(Director)
BoardJonathan Leff(Director)Robert Jackson(Director)
Co-investorsOUP (Osage University Partners)Deerfield Management Company
Elphogene develops oncoMonitor, a liquid biopsy molecular test that detects circulating tumor DNA (ctDNA) from patients' blood for non-invasive monitoring of cancer progression and treatment, primarily for colorectal cancer patients.
BiotechDigital HealthMedical DevicesPrague, CZ
Marek Minárik(Co-founder)
FUNBRUSH develops an antifouling and antibacterial nanocoating for biosensors and bioanalytical platforms, enabling sensitive detection in complex, undiluted sample media such as blood plasma, food, and environmental samples.
BiotechHealthtechNew Materials
Hana Lísalová(Founder & Head of Laboratory)
LAM-X develops nanofiber materials using patented light-activated photosensitizer technology that generates reactive oxygen species to kill microorganisms, applied to antimicrobial textiles and medical devices such as intravenous catheter dressings.
BiotechMedical DevicesNew MaterialsZlatníky-Hodkovice, CZ
Nanoflexion is a medtech spin-off developing an electrospun nanofiber surgical patch that acts as a biodegradable, biocompatible barrier to prevent anastomotic leakage and postoperative adhesions after colorectal and gastrointestinal surgery.
BiotechMedical DevicesNew Materials
Markéta Klíčová(Founder)inMarkéta Hujerová (Klíčová)(Founder)inMarketa Hujerova (Klicova), Ph.D.(Founder & CEO)
PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsItalian Angels for GrowthDoorwaySeventure PartnersCAP HORN VC
PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk.
BiotechConsumerHealthtechMedical DevicesNew MaterialsWellness & FitnessHalle (Saale), DE
Pierre Tangermann(CEO)inDr. Mirko Buchholz(Chief Scientific Officer)Dr. Nadine Taudte(Head of Biological Research)Jean-Marie Bryl(Head of Communications & Public Affairs)in
Co-investorsCompanistobmp Ventures
Sampling Human develops systems to generate actionable insights from individual biology using cellular-resolution data collection technologies.
AI & Machine LearningBiotechHealthtech
Daniel Georgiev(Co-Founder, CEO, and Board Member)inHynek Kasl(Co-Founder and Head of Engineering)inMartin Cienciala(Co-Founder and Head of Innovation)in
Co-investorsB3 Holdingi&i Biotech Fund
Sophomer is a Czech biotech company developing in vitro diagnostics (IVD) products, working in partnership with academic labs on the design and synthesis of new polymers.
BiotechHealthtechMedical DevicesNew Materials
Martin Burkhard(Founder & Managing Director – CEO, Operations & Development)Jan Plicka(Founder and Inventor & Managing Director – R&D)Jiří Moos(Founder and Inventor & Managing Director, Business Development)inTomáš Etrych(Founder and Inventor & Sophomer's Partner Lab)Libor Kostka(Founder and Inventor & Sophomer's Partner Lab)Vladimír Šubr(Founder and Inventor & Sophomer's Partner Lab)
Co-investorsi&i Biotech Fund
Sulfotools develops Clean Peptide Technology (CPT), a peptide synthesis process that replaces organic solvents with water, aimed at the pharmaceutical, chemical, and cosmetics industries.
BiotechCleantechNew Materials
Institute of Organic Chemistry and Biochemistry (IOCB) is a research institution under the Czech Academy of Sciences conducting basic research at the intersection of chemistry, biology, and computational sciences, with a systematic infrastructure for translating scientific discoveries into commercial products and technologies.
AI & Machine LearningBiotechDeep TechPrague, CZ
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Riocath
Portfolio news
latest coverage across their companiesSampling Human · nasdaqprivatemarket.com · Apr 3, 2026
PerioTrap · bmp.com · Mar 10, 2026
Frequently asked questions
- How many investments has Biotech Investments S.R.O made?
- Biotech Investments S.R.O has 18 tracked investments.
- What stage does Biotech Investments S.R.O invest at?
- Biotech Investments S.R.O invests at the Pre-Seed, Seed stages.
- What sectors does Biotech Investments S.R.O focus on?
- Biotech Investments S.R.O focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Biotech Investments S.R.O located?
- Biotech Investments S.R.O is headquartered in Prague, CZ.
- Who does Biotech Investments S.R.O co-invest with?
- Biotech Investments S.R.O most often shares deals with B3 Holding, Companisto, Italian Angels for Growth, among 5 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
InnoCom Bio Equities manages life science special purpose vehicles, offering investors a diversified portfolio of innovative life sciences technologies and providing seed capital to innovators and founders.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.